Details
Stereochemistry | ACHIRAL |
Molecular Formula | C37H44O4P |
Molecular Weight | 583.7166 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)=C(C)C1=O
InChI
InChIKey=OIIMUKXVVLRCAF-UHFFFAOYSA-N
InChI=1S/C37H44O4P/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32/h10-18,21-26H,4-9,19-20,27-28H2,1-3H3/q+1
Mitoquinone is a mitochondria-targeted antioxidant designed to accumulate within mitochondria in vivo in order to protect against oxidative damage. Mitoquinone comprises a positively charged lipophilic cation that drives its extensive accumulation within the negatively charged mitochondria inside cells. Because of the large mitochondria membrane potential, the cations accumulate within cellular mitochondria up to 1,000 fold, compared to non-targeted antioxidants such as Coenzyme Q or its analogs, enabling the antioxidant moiety to block lipid peroxidation and protect mitochondria from oxidative damage. By selectively blocking mitochondrial oxidative damage, it prevents cell death. Mitoquinone may help to prevent the nerve cell damage that leads to Parkinson's disease.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20492507
80 mg/day for 28 days.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11388332
Created by
admin on Sat Dec 16 11:54:08 GMT 2023 , Edited by admin on Sat Dec 16 11:54:08 GMT 2023
|
PRIMARY | |||
|
47BYS17IY0
Created by
admin on Sat Dec 16 11:54:08 GMT 2023 , Edited by admin on Sat Dec 16 11:54:08 GMT 2023
|
PRIMARY | |||
|
444890-41-9
Created by
admin on Sat Dec 16 11:54:08 GMT 2023 , Edited by admin on Sat Dec 16 11:54:08 GMT 2023
|
PRIMARY | |||
|
DB05063
Created by
admin on Sat Dec 16 11:54:08 GMT 2023 , Edited by admin on Sat Dec 16 11:54:08 GMT 2023
|
PRIMARY | |||
|
300000014661
Created by
admin on Sat Dec 16 11:54:08 GMT 2023 , Edited by admin on Sat Dec 16 11:54:08 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)